Log In
Print
BCIQ
Print
Print this Print this
 

elpamotide (OTS-102)

  Manage Alerts
Collapse Summary General Information
Company OncoTherapy Science Inc.
DescriptionAngiogenesis inhibitor that incorporates the KDR169 epitope of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1; VEGFR-2)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2)
Mechanism of ActionAngiogenesis inhibitor; Vaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today